PL2462154T3 - Nowa krystaliczna postać CDB-4124 i sposób jej wytwarzania - Google Patents

Nowa krystaliczna postać CDB-4124 i sposób jej wytwarzania

Info

Publication number
PL2462154T3
PL2462154T3 PL10747484T PL10747484T PL2462154T3 PL 2462154 T3 PL2462154 T3 PL 2462154T3 PL 10747484 T PL10747484 T PL 10747484T PL 10747484 T PL10747484 T PL 10747484T PL 2462154 T3 PL2462154 T3 PL 2462154T3
Authority
PL
Poland
Prior art keywords
cdb
preparation
crystal form
novel crystal
novel
Prior art date
Application number
PL10747484T
Other languages
English (en)
Inventor
Attila Balázs
János Csörgei
Ádám Demeter
Csaba Sánta
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Publication of PL2462154T3 publication Critical patent/PL2462154T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL10747484T 2009-08-05 2010-08-05 Nowa krystaliczna postać CDB-4124 i sposób jej wytwarzania PL2462154T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0900487A HUP0900487A2 (hu) 2009-08-05 2009-08-05 17-acetoxi-11ß-[4-(dimetil-amino)-fenil]-21-metoxi-19-norpregna-4,9-dién-3,20-dion új kristályos polimorf módosulata és eljárás elõállítására
PCT/HU2010/000088 WO2011015892A2 (en) 2009-08-05 2010-08-05 Novel crystal form of an organic compound and process for the preparation thereof
EP10747484.3A EP2462154B1 (en) 2009-08-05 2010-08-05 Novel crystal form of cdb-4124 and process for the preparation thereof

Publications (1)

Publication Number Publication Date
PL2462154T3 true PL2462154T3 (pl) 2015-12-31

Family

ID=89989159

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10747484T PL2462154T3 (pl) 2009-08-05 2010-08-05 Nowa krystaliczna postać CDB-4124 i sposób jej wytwarzania

Country Status (7)

Country Link
US (2) US9221870B2 (pl)
EP (1) EP2462154B1 (pl)
EA (1) EA019114B1 (pl)
ES (1) ES2546098T3 (pl)
HU (2) HUP0900487A2 (pl)
PL (1) PL2462154T3 (pl)
WO (1) WO2011015892A2 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0900171A2 (hu) 2009-03-20 2010-12-28 Richter Gedeon Nyrt 17-acetoxi-11ß-[4-(dimetil-amino)-fenil]-21-metoxi-19-norpregna-4,9-dién-3,20-dion új kristályos módosulata és eljárás elõállítására

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3921059A1 (de) * 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
DE4042007A1 (de) * 1990-12-22 1992-06-25 Schering Ag 6,7-modifizierte-11(beta)-aryl-4-estrene
DK0900234T3 (da) * 1996-05-01 2000-11-06 Us Gov Health & Human Serv 21-substituerede progesteronderivater anvendt som nye antigestagener
US6900193B1 (en) * 1996-05-01 2005-05-31 The United States Of America As Represented By The Department Of Health And Human Services Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
US6768014B2 (en) * 1999-12-29 2004-07-27 The United States Of America As Represented By The Department Of Health And Human Services PROCESS FOR PREPARING 17α-ACETOXY-11β-[4-N,N(DIMETHYLAMINO)PHENYL]-21-METHOXY-19-NORPREGNA-4,9-DIENE-3,20-DIONE, INTERMEDIATES USEFUL IN THE PROCESS , AND PROCESSES FOR PREPARING SUCH INTERMEDIATES
EP2033965A3 (en) 2000-03-17 2012-09-19 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents
US8044223B2 (en) * 2003-04-04 2011-10-25 Bridge Organics Co. Crystalline 19-norsteroids
US8173626B2 (en) * 2006-03-08 2012-05-08 Danco Laboratories Llc Methods, dosing regimens and medications using anti-progestational agents for the treatment of disorders
MX2009007313A (es) 2007-01-17 2009-07-15 Repros Therapeutics Inc Metodos para estabilidad mejorada de derivados de esteroides.
HU228636B1 (en) 2007-06-27 2013-04-29 Richter Gedeon Nyrt Industrial method for the synthesis of 17-acetoxy-11betha-4[-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione and the key intermediates of the process
TW201002736A (en) * 2008-04-28 2010-01-16 Repros Therapeutics Inc Compositions and methods for treating progesterone-dependent conditions
TWI477276B (zh) * 2008-04-28 2015-03-21 Repros Therapeutics Inc 抗黃體素給藥方案
HUP0900171A2 (hu) 2009-03-20 2010-12-28 Richter Gedeon Nyrt 17-acetoxi-11ß-[4-(dimetil-amino)-fenil]-21-metoxi-19-norpregna-4,9-dién-3,20-dion új kristályos módosulata és eljárás elõállítására

Also Published As

Publication number Publication date
EA201200241A1 (ru) 2012-07-30
HUE025397T2 (en) 2016-02-29
WO2011015892A3 (en) 2011-03-31
EA019114B1 (ru) 2014-01-30
HUP0900487A2 (hu) 2011-03-28
US20120142655A1 (en) 2012-06-07
US20160220585A1 (en) 2016-08-04
EP2462154B1 (en) 2015-06-24
WO2011015892A2 (en) 2011-02-10
HU0900487D0 (en) 2009-09-28
ES2546098T3 (es) 2015-09-18
EP2462154A2 (en) 2012-06-13
US9221870B2 (en) 2015-12-29

Similar Documents

Publication Publication Date Title
ZA201202504B (en) Process for the preparation of calcobutrol
IL215999A0 (en) Processes for the preparation of rivaroxaban and intermediates thereof
SI2477992T1 (sl) Postopki za pripravo darunavirja in njega amorfne oblike
EP2444398A4 (en) NEW INTERMEDIATE PRODUCTS FROM VORICONAZOLE AND PRODUCTION PROCESS FOR VORICONAZOLE THEREWITH
SI2387566T1 (sl) Postopek za pripravo rosuvastatina
PL2151428T3 (pl) Nowy sposób syntezy agomelatyny
PL390042A1 (pl) Sposób wytwarzania kwasu chlebowego
IL208792A0 (en) Process for the preparation of amides
ZA201202343B (en) Process for the preparation of lenalidomide
PL388931A1 (pl) Sposób otrzymywania fluorokarbofunkcyjnych silseskwioksanów
IL219913A (en) A process for preparing tapentadol and its intermediates
EG26332A (en) Process for the preparation of benzonoprons
EP2388248A4 (en) PROCESSES FOR THE PREPARATION OF IVABRADINE SULFATE AND ITS CRYSTALLINE FORM I
PL2151429T3 (pl) Nowy sposób syntezy agomelatyny
PL2462154T3 (pl) Nowa krystaliczna postać CDB-4124 i sposób jej wytwarzania
EG27000A (en) Process for the preparation of ibodutant (MEN15596) and related intermediates
IL217460A0 (en) Novel process for the preparation of 4-aminobut-2-enolides
PL389013A1 (pl) Nowe winylo-alkinylopodstawione związki germanu oraz sposób otrzymywania winylo-alkinylopodstawionych związków germanu
SI2387557T1 (sl) Postopek za pripravo N-(5-(3-dimetilamino-akriloil)-2-fluorofenil)-N-metil-acetamida
IL211382A0 (en) Process for the preparation of ethanedinitrile
PL391702A1 (pl) Sposób otrzymywania 5-hydroksykreatyniny i N-metyloguanidyny
IL220160A (en) A process for the preparation of defrasirox
PL389568A1 (pl) Sposób otrzymywania 2-metyloglicydolu
PL393506A1 (pl) Imidy monoacylowinowe i sposób otrzymywania imidów monoacylowinowych
PL388932A1 (pl) Sposób otrzymywania fluorosilikonów i ich pochodnych